Skip to main content
Log in

Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström’s macroglobulinemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig.1

References

  1. Pruzanski W, Katz A (1984) Cold agglutinins-antibodies with biological diversity. Clin Immunol Rev 3:131–168

    CAS  PubMed  Google Scholar 

  2. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, Ghanima W, Shammas FV, Tjonnfjord GE (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 103:2925–2928

    Article  CAS  PubMed  Google Scholar 

  3. Rosse WF, Adams JP (1980) The variability of hemolysis in the cold agglutinin syndrome. Blood 56:409–416

    CAS  PubMed  Google Scholar 

  4. Petz LD (2008) Cold antibody autoimmune hemolytic anemias. Blood Rev 22:1–15

    Article  PubMed  Google Scholar 

  5. Schöllkopf C, Kjeldsen L, Bjerrum OW, Mourits-Andersen HT, Nielsen JL, Christensen BE, Jensen BA, Pedersen BB, Taaning EB, Klausen TW, Birgens H (2006) Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leuk Lymphoma 47:253–260

    Article  PubMed  Google Scholar 

  6. Salama A, Göttsche B, Vaidya V, Santoso S, Mueller-Eckhardt C (1988) Complement-independent lysis of human red blood cells by cold hemagglutinins. Vox Sang 55:21–25

    Article  CAS  PubMed  Google Scholar 

  7. Berentsen S, Beiske K, Tjonnfjord GE (2007) Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. Hematology 12:361–370

    Article  PubMed  Google Scholar 

  8. Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, Röth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355:1233–1243

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norimichi Hattori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hattori, N., Ishii, N., Ariizumi, H. et al. Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström’s macroglobulinemia. Ann Hematol 89, 103–104 (2010). https://doi.org/10.1007/s00277-009-0773-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-009-0773-z

Keywords

Navigation